Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Mar 27;22(4):561–570. doi: 10.1158/1055-9965.EPI-12-1356

Table 1.

Estimated number of cancer survivors by age, gender and cancer site as of January 1, 2012 (invasive cancers and 1st primary cases only)

All ages 0–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80+
All sites
  Male 6,442,282 18,499 43,137 74,785 134,634 350,354 930,143 1,705,730 1,858,259 1,326,741
  Female 7,241,571 8,636 36,912 105,114 250,921 647,838 1,365,042 1,801,428 1,607,632 1,418,047
  Total 13,683,853 2,7135 80,049 179,899 385,555 998,192 2,295,185 3,507,158 3,465,891 2,744,788

Bladder
  Male 437,179 15 112 590 2,700 13,220 49,481 109,759 141,414 119,888
  Female 148,208 22 102 350 1,131 4,450 15,161 32,660 44,590 49,743
  Total 585,387 37 214 940 3,831 17,670 64,642 142,419 186,004 169,631
Breast
  Male * * * * * * * * * *
  Female 2,971,606 0 27 2,658 40,168 226,604 599,361 808,281 696,389 598,118
  Total 2,971,606 0 27 2,658 40,168 226,604 599,361 808,281 696,389 598,118
Cervix
  Male * * * * * * * * * *
  Female 245,022 0 61 2,333 13,823 36,239 56,852 57,009 42,848 35,856
  Total 245,022 0 61 2,333 13,823 36,239 56,852 57,009 42,848 35,856
Colorectal
  Male 595,213 9 105 846 4,744 23,681 82,493 158,470 180,450 144,415
  Female 603,527 11 138 1,034 5,174 22,995 73,927 137,208 170,380 192,659
  Total 1,198,740 20 243 1,880 9,918 46,676 156,421 295,678 350,830 337,074
Oral cavity
  Male 185,242 54 274 1,089 3,874 15,150 42,487 57,738 40,628 23,948
  Female 95,521 102 467 1,343 3,155 8,275 18,320 24,770 20,958 18,131
  Total 280,763 156 741 2,432 7,030 23,425 60,807 82,508 61,585 42,079
Kidney
  Male 212,996 1,602 2,344 2,419 4,149 15,494 42,469 62,523 51,422 30,573
  Female 147,882 1,767 2,955 3,035 4,202 11,509 26,474 36,683 33,386 27,871
  Total 360,878 3,368 5,299 5,455 8,351 27,003 68,943 99,206 84,808 58,444
Leukemia
  Male 167,737 5,704 11,242 13,467 13,842 18,282 27,358 32,441 27,210 18,192
  Female 130,428 4,977 9,244 10,910 110,58 14,044 19,819 22,489 19,912 17,975
  Total 298,165 10,680 20,486 24,376 24,900 32,326 47,177 54,929 47,122 36,167
Lung
  Male 189,077 0 6 76 746 5,799 25,758 57,097 60,794 38,800
  Female 223,149 1 15 154 1,141 7,332 29,405 61,049 67,547 56,503
  Total 412,226 2 21 230 1,887 13,131 55,163 11,8147 128,342 95,303
Melanoma
  Male 481,040 48 799 5,367 18,944 52,796 105,289 129,682 102,888 65,227
  Female 496,210 52 1,443 11,177 35,356 77,324 117,430 112,466 78,783 62,179
  Total 977,250 100 2,242 16,544 54,300 130,121 222,719 242,147 181,672 127,407
Ovary
  Male * * * * * * * * * *
  Female 192,753 46 891 3,016 6,819 18,913 41,155 50,762 39,499 31,652
  Total 192,753 46 891 3,016 6,819 18,913 41,155 50,762 39,499 31,652
Prostate
  Male 2,778,626 0 0 11 770 23,149 236,096 783,687 1,005,993 728,921
  Female * * * * * * * * * *
  Total 2,778,626 0 0 11 770 23,149 236,096 783,687 1,005,993 728,921
Corpus
  Male * * * * * * * * * *
  Female 606,913 0 21 586 4,558 24,947 89,380 163,951 167,142 156,328
  Total 606,913 0 21 586 4,558 24,947 89,380 163,951 167,142 156,328
Hodgkin lymphoma
  Male 96,841 150 2,186 9,458 16,391 21,726 22,589 15,114 6,546 2,681
  Female 91,751 65 1,835 10,195 17,763 21,359 19,743 12,081 5,533 3,177
  Total 188,591 214 4,021 19,653 34,154 43,084 42,333 27,195 12,079 5,858
Non-Hodgkin lymphoma
  Male 279495 648 2,709 6,117 12,484 29,062 58,052 73,431 59,868 37,125
  Female 255454 416 1,927 4,722 9,068 20,765 44,767 62,484 58,686 52,620
  Total 534949 1,063 4,636 10,839 21,552 49,827 102,819 135,915 118,553 89,744
Thyroid
  Male 121,670 21 431 2,913 8,942 19,912 30,854 29,542 18,717 10,340
  Female 436,590 39 1,657 14,742 44,872 84,921 108,822 89,072 54,022 38,443
  Total 558,261 60 2,087 17,655 53,814 104,832 139,676 118,614 72,739 48,783
Testis
  Male 230,913 73 2,210 16,124 40,917 61,946 60,052 33,768 11,767 4055
  Female * * * * * * * * * *
  Total 230,913 73 2,210 16,124 40,917 61,946 60,052 33,768 11,767 4,055

Note: Table one includes prevalence data for all cancer sites combined and data for the 16 most prevalent cancer sites.